Vaneltix Pharma, Inc.
Clinical trials sponsored by Vaneltix Pharma, Inc., explained in plain language.
-
New bladder pain cocktail aims to ease Flare-Ups fast
Symptom relief Recruiting nowThis study tests a single dose of VNX001, a mix of lidocaine and heparin, to quickly reduce moderate to severe bladder pain in people with interstitial cystitis/bladder pain syndrome. About 120 adults with a history of IC/BPS for at least 9 months will receive either VNX001, plac…
Phase: PHASE2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New bladder pain treatment shows promise in early trial
Symptom relief Recruiting nowThis study tests a drug called VNX001 for people with Interstitial Cystitis (a painful bladder condition) who have sudden, moderate-to-severe bladder pain. About 50 adults will receive up to 6 doses of the drug directly into the bladder over 14 days. The goal is to see if the dru…
Phase: PHASE2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC